The trial tested a new chemo combination aimed at mopping up remaining tumor cells by giving patients the two drugs in wide use and adding a third, Pharmacia's Camptosar.
Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems.
Now, if you had a combination therapy with nanoparticles, the drugs would slowly release into the tumor cells and you would have high, sustained levels of drug in the tumor.
It improved upon older radiation technology with a combination of new software and hardware that could mold a radiation beam to match the shape of a tumor.